» Authors » David Neal

David Neal

Explore the profile of David Neal including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 67
Citations 2494
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Neal D, Gaber S, Joddrell P, Brorsson A, Dijkstra K, Droes R
Digit Health . 2023 Jan; 9:20552076231152162. PMID: 36698427
Objective: Trust and accessibility are vital to adoption of health and wellness apps. This research scoped three elements of cognitive accessibility of health app privacy policies: availability, ease of navigation,...
2.
Peute L, Wildenbos G, Engelsma T, Lesselroth B, Lichtner V, Monkman H, et al.
Yearb Med Inform . 2022 Jun; 31(1):74-81. PMID: 35654432
Objectives: Involving representative users in usability testing of health information technology (HIT) is central to user-centered design. However, (vulnerable) older adults as representative users have unique requirements. Aging processes may...
3.
Neal D, Engelsma T, Tan J, Craven M, Marcilly R, Peute L, et al.
Lancet Digit Health . 2022 Jan; 4(2):e80-e82. PMID: 35090677
No abstract available.
4.
Neal D
BMJ Surg Interv Health Technol . 2022 Jan; 1(1):e000015. PMID: 35047778
No abstract available.
5.
Kuci Emruli V, Liljedahl L, Axelsson U, Richter C, Theorin L, Bjartell A, et al.
Proteomics Clin Appl . 2021 Feb; 15(2-3):e2000025. PMID: 33580906
Purpose: Improved early diagnosis and determination of aggressiveness of prostate cancer (PC) is important to select suitable treatment options and to decrease over-treatment. The conventional marker is total prostate specific...
6.
Neal D, van den Berg F, Planting C, Ettema T, Dijkstra K, Finnema E, et al.
J Clin Med . 2021 Feb; 10(4). PMID: 33562749
There is increasing interest in the use of technology to support social health in dementia. The primary objective of this systematic review was to synthesize evidence of effectiveness of digital...
7.
Wade J, Donovan J, Lane A, Davis M, Walsh E, Neal D, et al.
BMJ Open . 2020 Sep; 10(9):e036024. PMID: 32907896
Objectives: Active surveillance (AS) enables men with low risk, localised prostate cancer (PCa) to avoid radical treatment unless progression occurs; lack of reliable AS protocols to determine progression leaves uncertainties...
8.
Hamdy F, Donovan J, Athene Lane J, Mason M, Metcalfe C, Holding P, et al.
Health Technol Assess . 2020 Aug; 24(37):1-176. PMID: 32773013
Background: Prostate cancer is the most common cancer among men in the UK. Prostate-specific antigen testing followed by biopsy leads to overdetection, overtreatment as well as undertreatment of the disease....
9.
Neal D, Beckwith T, Hines A, Lee W, Kilinc B, Jo C, et al.
J Orthop . 2019 Sep; 16(5):440-444. PMID: 31516214
Objective: Although the Pavlik Harness (PH) is the most utilized treatment for developmental dysplasia of the hip (DDH), the ideal treatment protocol (frequency of clinic visits in the first month...
10.
Jiang X, Dimou N, Al-Dabhani K, Lewis S, Martin R, Haycock P, et al.
Int J Epidemiol . 2019 Jan; 48(5):1416-1424. PMID: 30597039
Background: Observational studies have suggested an association between circulating vitamin D concentrations [25(OH)D] and risk of breast and prostate cancer, which was not supported by a recent Mendelian randomization (MR)...